Survey Finds 51% of Brands Prefer Advertising on Facebook image
Quite simply, brands prefer Facebook because it is by far the most populated social network. As of March of this year Facebook has claimed 1.1 billion active users worldwide. Among the largest markets, according to Socialbakers’ statistics, over 78% of Internet users in the United States are on Facebook, with 68% in the United Kingdom, and almost 76% in Australia. A social network of this magnitude produces connections between brands and fans, and friends of fans that were previously impossible to notice.
According to a recent survey conducted by Socialbakers, of the four of the biggest social networks Facebooktrumps Twitter, LinkedIn and YouTube. But there are reasons besides population size that make Facebook an exciting place for advertisers
Wall Street 9/24/13 By: Mark Lawson
Citigroup’s Analyst Mark May wrote in an investor note that the catalysts that enabled Facebook to post strong second-quarter results should continue. Subsequent to chats with several Facebook advertisers, May reported that a number of them are hiking their spending on the social network by some 15 percent this quarter, and that ad prices continue to rise and desktop ads remain effective.
Seeking Alpha Market Currents 9/23/13
Leerink sees big upside for Celldex on CDX-1127 potential
After "closely examining" some available data and speaking with "several MEDACorp key opinion leaders," Leerink thinks Celldex's (CLDX +3.3%) CDX-1127 has quite a bit of potential as a co-stimulatory agonist.
Drawing a parallel with the Hep C space (where combo treatments have produced impressive results), analyst Howard Liang says CDX-1127 may be positioned "as one of the leading candidates for PD-1 combination" if CLDX presents data showing the drug has some "single-agent activity [and] a clean safety profile."
Look for data in November at the Society for Immunotherapy of Cancer meeting.
CLDX maintained at Buy.
Price target raised to $45 from $28